These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6283708)

  • 1. 19-nor-deoxycorticosterone excretion in healthy and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Trans Assoc Am Physicians; 1981; 94():301-9. PubMed ID: 6283708
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
    Gomez-Sanchez CE; Holland OB; Upcavage R
    J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)].
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259
    [No Abstract]   [Full Text] [Related]  

  • 5. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adrenocorticotropin on desoxycorticosterone, corticosterone and aldosterone excretion.
    Biglieri EG; Shambelan M; Slaton PE
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1090-101. PubMed ID: 4308415
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary 19-nor-deoxycorticosterone and deoxycorticosterone in hypertensive disease of pregnancy.
    Shah DM; Gomez-Sanchez CE; Knuppel RA; Vaughn WK
    Am J Perinatol; 1987 Apr; 4(2):102-5. PubMed ID: 3566877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ACTH administration on urinary kallikrein excretion in man.
    Whitworth JA; van Leeuwen BH; Hannah MC; Scoggins BA; Thatcher R
    Clin Exp Pharmacol Physiol; 1984; 11(1):87-90. PubMed ID: 6325055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma deoxycorticosterone and aldosterone in essential hypertension.
    Honda M; Nowaczynski W; Messerli FH; Kuchel O; Genest J
    J Steroid Biochem; 1976 Aug; 7():565-9. PubMed ID: 183059
    [No Abstract]   [Full Text] [Related]  

  • 11. 18-hydroxy-11-deoxycorticosterone response to ACTH, insulin and furosemide administration in essential hypertensive patients.
    Tosti-Croce C; Giaquinto G; Graziosi S; Odoardi A; Sparano F; Sciarra F
    Horm Res; 1981; 15(1):28-36. PubMed ID: 6277757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 19-nor-deoxycorticosterone excretion in the spontaneously hypertensive rat.
    Dale SL; Holbrook MM; Komanicky P; Melby JC
    Endocrinology; 1982 Jun; 110(6):1989-93. PubMed ID: 7075546
    [No Abstract]   [Full Text] [Related]  

  • 13. Two cases of low-renin hypertension thought to be due to excessive secretion of unknown mineralocorticoid.
    Haruyama K; Yamazaki M; Toki T; Fukuchi S
    Jpn Circ J; 1982 Feb; 46(2):156-61. PubMed ID: 6276583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxycorticosterone excretion in normal, hypertensive and hypokalaemic subjects.
    Cope CL; Loizou S
    Clin Sci Mol Med; 1975 Feb; 48(2):97-105. PubMed ID: 1167821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
    Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD
    Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
    [No Abstract]   [Full Text] [Related]  

  • 16. [Corticotropin studies in essential hypertension].
    Julesz J
    Z Gesamte Inn Med; 1983 Aug; 38(15):408-10. PubMed ID: 6314685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H; Wocial B; Skórka B; Chodakowska J; Nazar K; Chwalbińska-Moneta J
    Acta Physiol Pol; 1980; 31(6):631-5. PubMed ID: 7018172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J; Messerli FH; Honda M; Tolis G; Seth K; Parvin-Pande R; Kubo S; Grose J; Ledoux F; Lebel M
    J Steroid Biochem; 1975 May; 6(5):767-78. PubMed ID: 171513
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of steroids in human essential hypertension.
    Gomez-Sanchez CE
    Biochem Pharmacol; 1982 Mar; 31(6):893-7. PubMed ID: 6282283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.